US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
KR0162872B1
(ko)
*
|
1996-04-01 |
1998-12-01 |
김은영 |
용매추출법을 이용한 생분해성 고분자 미립구의 개선된 제조방법 및 이를 이용한 국소염증 질환 치료용 미립구의 제조방법
|
US7276251B2
(en)
*
|
1997-04-01 |
2007-10-02 |
Lg Life Sciences, Ltd., Inc. |
Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
|
KR100236771B1
(ko)
*
|
1997-04-01 |
2000-02-01 |
성재갑 |
히아루론산을 이용한 약물의 서방성 미세입자 제형
|
TW586934B
(en)
*
|
1997-05-19 |
2004-05-11 |
Sumitomo Pharma |
Immunopotentiating composition
|
US6156347A
(en)
*
|
1998-01-21 |
2000-12-05 |
Bio-Dar Ltd. |
Controlled release chromium picolinate
|
US7087236B1
(en)
|
1998-09-01 |
2006-08-08 |
Merrion Research I Limited |
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
|
GB9819272D0
(en)
*
|
1998-09-03 |
1998-10-28 |
Andaris Ltd |
Microparticles
|
IL138468A0
(en)
|
1999-01-18 |
2001-10-31 |
Lg Chemical Ltd |
Solid lipophilic microparticles contining a protein or peptide drug
|
KR100359252B1
(ko)
*
|
1999-12-21 |
2002-11-04 |
주식회사 엘지생명과학 |
항원을 포함하는 고체상 미세입자 및 이를 포함하는 제제
|
US6723342B1
(en)
|
1999-02-08 |
2004-04-20 |
Fmc Corporation |
Edible coating composition
|
US6432448B1
(en)
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
PT1218001E
(pt)
*
|
1999-09-03 |
2009-03-31 |
Sigma Tau Ind Farmaceuti |
L-carnitina ultrafina, métodos de preparação da mesma, composições contendo a mesma, e métodos de utilização da mesma
|
US6500462B1
(en)
|
1999-10-29 |
2002-12-31 |
Fmc Corporation |
Edible MCC/PGA coating composition
|
GB0000891D0
(en)
*
|
2000-01-14 |
2000-03-08 |
Allergy Therapeutics Ltd |
Formulation
|
WO2001058466A1
(en)
*
|
2000-02-08 |
2001-08-16 |
Institute Of Molecular Agrobiology |
Biodegradable and biocompatible polymeric microspheres encapsulating salmonella enteritidisbacteria
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
GB0017999D0
(en)
*
|
2000-07-21 |
2000-09-13 |
Smithkline Beecham Biolog |
Novel device
|
US20060177416A1
(en)
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
SE517421C2
(sv)
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
|
SE517422C2
(sv)
|
2000-10-06 |
2002-06-04 |
Bioglan Ab |
Farmaceutiskt acceptabel stärkelse
|
WO2002028375A1
(en)
|
2000-10-06 |
2002-04-11 |
Jagotec Ag |
A controlled-release, parenterally administrable microparticle preparation
|
SE518007C2
(sv)
|
2000-11-16 |
2002-08-13 |
Bioglan Ab |
Förfarande för framställning av mikropartiklar
|
SE518008C2
(sv)
*
|
2000-11-16 |
2002-08-13 |
Bioglan Ab |
Parenteralt administrerbara mikropartiklar och förfarande för framställning av desamma
|
US6699315B2
(en)
|
2000-11-28 |
2004-03-02 |
Fmc Corporation |
Edible PGA coating composition
|
US20070142325A1
(en)
*
|
2001-01-08 |
2007-06-21 |
Gustavsson Nils O |
Starch
|
EP2545937A1
(en)
*
|
2001-06-05 |
2013-01-16 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
US6967234B2
(en)
*
|
2002-12-18 |
2005-11-22 |
Ethicon, Inc. |
Alkyd-lactone copolymers for medical applications
|
US7030127B2
(en)
*
|
2001-06-29 |
2006-04-18 |
Ethicon, Inc. |
Composition and medical devices utilizing bioabsorbable polymeric waxes
|
US7034037B2
(en)
|
2001-06-29 |
2006-04-25 |
Ethicon, Inc. |
Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin
|
US7105181B2
(en)
*
|
2001-10-05 |
2006-09-12 |
Jagotec, Ag |
Microparticles
|
SE0201599D0
(sv)
*
|
2002-03-21 |
2002-05-30 |
Skyepharma Ab |
Microparticles
|
US7005136B2
(en)
|
2002-03-29 |
2006-02-28 |
Ethicon, Inc. |
Bone replacement materials utilizing bioabsorbable liquid polymers
|
US7326426B2
(en)
*
|
2002-03-29 |
2008-02-05 |
Ethicon, Inc. |
Compositions and medical devices utilizing bioabsorbable liquid polymers
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
KR100479735B1
(ko)
*
|
2002-05-25 |
2005-03-30 |
이현철 |
대식세포특이 나노입자-면역조절제-면역원 복합체를이용한 치아우식증을 예방하는 비경구용 백신
|
US7368125B2
(en)
*
|
2002-06-05 |
2008-05-06 |
Ethicon, Inc. |
Amphiphilic polymers for medical applications
|
US7026374B2
(en)
*
|
2002-06-25 |
2006-04-11 |
Aruna Nathan |
Injectable microdispersions for medical applications
|
US7101566B2
(en)
*
|
2002-06-28 |
2006-09-05 |
Ethicon, Inc. |
Polymer coated microparticles for sustained release
|
FR2842737B1
(fr)
*
|
2002-07-25 |
2006-01-27 |
Centre Nat Rech Scient |
Particules revetues en surface de hyaluronane ou d'un de ses derives et leur utilisation a titre de vecteurs biologiques pour des matieres actives
|
US20040047835A1
(en)
*
|
2002-09-06 |
2004-03-11 |
Cell Therapeutics, Inc. |
Combinatorial drug therapy using polymer drug conjugates
|
US6872799B2
(en)
|
2002-12-18 |
2005-03-29 |
Ethicon, Inc. |
Functionalized polymers for medical applications
|
US6866860B2
(en)
|
2002-12-19 |
2005-03-15 |
Ethicon, Inc. |
Cationic alkyd polyesters for medical applications
|
US20070218139A1
(en)
*
|
2002-12-20 |
2007-09-20 |
Smith Thomas J |
High Pressure Compaction For Pharmaceutical Formulations
|
US20040120981A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Aruna Nathan |
Crosslinked alkyd polyesters for medical applications
|
US7446131B1
(en)
*
|
2004-06-10 |
2008-11-04 |
The United States Of America As Represented By The Secretary Of Agriculture |
Porous polymeric matrices made of natural polymers and synthetic polymers and optionally at least one cation and methods of making
|
WO2006059846A1
(en)
*
|
2004-12-01 |
2006-06-08 |
Lg Life Sciences, Ltd. |
Formulation of sec1 mutated protein and method for formulation of the same
|
EP1726299A3
(en)
*
|
2005-05-27 |
2007-04-18 |
StratoSphere Pharma AB |
Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
|
CA2623239C
(en)
*
|
2005-09-22 |
2016-07-12 |
Medivas, Llc |
Solid polymer delivery compositions and methods for use thereof
|
CA2623198C
(en)
|
2005-09-22 |
2014-08-05 |
Medivas, Llc |
Bis-(a-amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
|
US20070134332A1
(en)
*
|
2005-11-21 |
2007-06-14 |
Medivas, Llc |
Polymer particles for delivery of macromolecules and methods of use
|
EP1962894A4
(en)
*
|
2005-12-07 |
2012-11-14 |
Medivas Llc |
PROCESS FOR ASSEMBLING A BIOLOGICAL POLYMER-AGENT DELIVERY COMPOSITION
|
WO2007130477A2
(en)
*
|
2006-05-02 |
2007-11-15 |
Medivas, Llc |
Delivery of ophthalmologic agents to the exterior or interior of the eye
|
WO2007133616A2
(en)
*
|
2006-05-09 |
2007-11-22 |
Medivas, Llc |
Biodegradable water soluble polymers
|
CA2709412A1
(en)
*
|
2007-07-24 |
2009-01-29 |
Medivas, Llc |
Biodegradable cationic polymer gene transfer compositions and methods of use
|
US9415006B2
(en)
*
|
2008-05-23 |
2016-08-16 |
The Regents Of The University Of Michigan |
Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same
|
CA2733686A1
(en)
*
|
2008-08-13 |
2010-02-18 |
Medivas, Llc |
Aabb-poly(depsipeptide) biodegradable polymers and methods of use
|
US20110020392A1
(en)
*
|
2008-10-14 |
2011-01-27 |
Salubrious Pharmaceutical, Llc |
Process for treatment of rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis and non-viral based cancers
|
US9060934B2
(en)
*
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8409376B2
(en)
|
2008-10-31 |
2013-04-02 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8762067B2
(en)
*
|
2008-10-31 |
2014-06-24 |
The Invention Science Fund I, Llc |
Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
|
US8725420B2
(en)
*
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8793075B2
(en)
|
2008-10-31 |
2014-07-29 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9056047B2
(en)
|
2008-10-31 |
2015-06-16 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US8545855B2
(en)
*
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8603496B2
(en)
*
|
2008-10-31 |
2013-12-10 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US9060931B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US8551506B2
(en)
*
|
2008-10-31 |
2013-10-08 |
The Invention Science Fund I, Llc |
Compositions and methods for administering compartmentalized frozen particles
|
US8788211B2
(en)
*
|
2008-10-31 |
2014-07-22 |
The Invention Science Fund I, Llc |
Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
|
US9050070B2
(en)
*
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8485861B2
(en)
*
|
2008-10-31 |
2013-07-16 |
The Invention Science Fund I, Llc |
Systems, devices, and methods for making or administering frozen particles
|
US8858912B2
(en)
*
|
2008-10-31 |
2014-10-14 |
The Invention Science Fund I, Llc |
Frozen compositions and methods for piercing a substrate
|
US8545857B2
(en)
*
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for administering compartmentalized frozen particles
|
US8603495B2
(en)
*
|
2008-10-31 |
2013-12-10 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US20100111834A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Compositions and methods for therapeutic delivery with frozen particles
|
US8731840B2
(en)
*
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9060926B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9072688B2
(en)
*
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9072799B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8731841B2
(en)
*
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8551505B2
(en)
*
|
2008-10-31 |
2013-10-08 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9050317B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US20100111857A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Boyden Edward S |
Compositions and methods for surface abrasion with frozen particles
|
US8721583B2
(en)
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
ES2566646T3
(es)
*
|
2009-06-16 |
2016-04-14 |
The Regents Of The University Of Michigan |
Vacunas en nanoemulsión
|
EP2515864A4
(en)
*
|
2009-12-23 |
2013-09-11 |
Psivida Inc |
DELAYED RELEASE DELIVERY DEVICES
|
JP5805195B2
(ja)
|
2010-08-23 |
2015-11-04 |
カンステム バイオテック カンパニー リミテッド |
Nod2アゴニストで処理した幹細胞またはその培養物を含む免疫疾患および炎症性疾患の予防および治療用の薬学的組成物
|
WO2012082765A2
(en)
|
2010-12-16 |
2012-06-21 |
The United State Of America. As Represented By The Secretary Department Of Health And Human Services |
Methods for decreasing body weight and treating diabetes
|
CA2830600C
(en)
|
2011-03-23 |
2021-07-27 |
Tomokazu AMANO |
Compositions and methods for enhancing the pluripotency of stem cells
|
EP2696869B1
(en)
|
2011-04-12 |
2017-08-23 |
Rigel Pharmaceuticals, Inc. |
Methods for inhibiting allograft rejection
|
AU2012256014B2
(en)
|
2011-05-13 |
2016-10-27 |
Elixirgen, Llc |
Use of Zscan4 and Zscan4-dependent genes for direct reprogramming of somatic cells
|
US9873765B2
(en)
|
2011-06-23 |
2018-01-23 |
Dsm Ip Assets, B.V. |
Biodegradable polyesteramide copolymers for drug delivery
|
WO2012175746A1
(en)
|
2011-06-23 |
2012-12-27 |
Dsm Ip Assets B.V. |
New biodegradable polyesteramide copolymers for drug delivery
|
JP6099098B2
(ja)
*
|
2011-11-17 |
2017-03-22 |
国立大学法人富山大学 |
生理活性物質徐放制御組成物
|
WO2013163176A1
(en)
|
2012-04-23 |
2013-10-31 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
CN105246490A
(zh)
|
2013-03-15 |
2016-01-13 |
伊利克斯根公司 |
使用zscan4复壮人细胞的方法
|
WO2014153541A1
(en)
|
2013-03-21 |
2014-09-25 |
Eupraxia Pharmaceuticals USA LLC |
Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
|
CN105188741A
(zh)
|
2013-04-03 |
2015-12-23 |
阿勒丁医疗公司 |
新型纳米颗粒组合物
|
JP2016519152A
(ja)
*
|
2013-05-22 |
2016-06-30 |
ユーシービー バイオファルマ エスピーアールエル |
治療用タンパク質を含む粒子を製造する方法
|
EP2805708A1
(en)
*
|
2013-05-22 |
2014-11-26 |
UCB Pharma, S.A. |
Methods to produce particles comprising therapeutic proteins
|
US9925241B2
(en)
|
2013-10-21 |
2018-03-27 |
Salk Institute For Biological Studies |
Mutated fibroblast growth factor (FGF) 1 and methods of use
|
MX2016011517A
(es)
|
2014-03-07 |
2017-04-13 |
Univ Arizona |
Peptidos de crmp2 no narcoticos que seleccionan como diana canales de sodio para el dolor cronico.
|
AU2015366355B2
(en)
|
2014-12-18 |
2020-05-28 |
Dsm Ip Assets B.V. |
Drug delivery system for delivery of acid sensitive drugs
|
EP3206672B1
(en)
|
2015-10-27 |
2018-03-14 |
Eupraxia Pharmaceuticals Inc. |
Sustained release formulations of local anesthetics
|
WO2018160772A1
(en)
|
2017-02-28 |
2018-09-07 |
The United State Of America, As Represented By The Secretary, Department Of Health & Human Services |
Method of treating obesity, insulin resistance, non-alcoholic fatty liver disease including non-alcoholic steatohepatitis
|
CN107375921B
(zh)
*
|
2017-06-12 |
2019-10-29 |
商丘美兰生物工程有限公司 |
一种甘草皂苷脂质体免疫佐剂及其制备方法
|
CA3094345A1
(en)
|
2018-04-12 |
2019-10-17 |
Krystal Biotech, Inc. |
Compositions and methods for the treatment of autosomal recessive congenital ichthyosis
|
CA3112627A1
(en)
|
2018-09-24 |
2020-04-02 |
Krystal Biotech, Inc. |
Compositions and methods for the treatment of netherton syndrome
|
CA3112633A1
(en)
|
2018-09-26 |
2020-04-02 |
Krystal Biotech, Inc. |
Compositions and methods for the treatment of skin diseases
|
US10829529B2
(en)
|
2019-02-08 |
2020-11-10 |
Krystal Biotech, Inc. |
Compositions and methods for delivering CFTR polypeptides
|
US20220054494A1
(en)
|
2019-03-13 |
2022-02-24 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods for treating bladder and urethra dysfunction and disease
|
EP4025699A1
(en)
|
2019-09-03 |
2022-07-13 |
Krystal Biotech, Inc. |
Compositions and methods for the treatment of congenital ichthyoses
|
EP4077688A1
(en)
|
2019-12-20 |
2022-10-26 |
Krystal Biotech, Inc. |
Compositions and methods for gene delivery to the airways and/or lungs
|
US20230181672A1
(en)
|
2020-05-07 |
2023-06-15 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Aberrant post-translational modifications (ptms) in methyl- and propionic acidemia and a mutant sirtuin (sirt) to metabolize ptms
|
CN117412986A
(zh)
|
2021-04-02 |
2024-01-16 |
克里斯托生物技术股份有限公司 |
用于癌症疗法的病毒载体
|